5th Edition of International Conference on Tissue Engineering and Regenerative Medicine
September 18-20 | London, UK
Disease Modeling and Personalized Regenerative Medicine
Tailored solutions for complex diseases require systems that replicate patient-specific conditions. Disease modeling and personalized regenerative medicine combine 3D tissue models, patient-derived cells, and bioengineered platforms to predict treatment responses and design targeted therapies. By recreating pathological environments in vitro, researchers can evaluate drug efficacy and explore disease progression mechanisms. This approach reduces dependency on animal models and improves translational relevance. Integration with genomic data, artificial intelligence, and bioprinting allows for highly individualized therapeutic planning. Disease modeling and personalized regenerative medicine enhances precision medicine by aligning cellular behavior with specific genetic and environmental factors, making regenerative interventions more effective and patient-centered.
Kara E McCloskey
University of California, Merced, United States
Thomas J Webster
Interstellar Therapeutics, United States
Nagy Habib
Imperial College London, United Kingdom
Jaber Jamil Haj Ali
Consulting Medical Lab, State of Palestine
Roberto Gramignoli
IRCCS Gaslini Institute, Italy
Vasiliki E Kalodimou
Director Flow Cytometry-Research, Greece
Kunal Mitra
Florida Tech, United StatesSubmit your abstract Today
Title : Eliminating implants infections with nanomedicine: Human results
Thomas J Webster, Interstellar Therapeutics, United States
Title : Graphene, butterfly structures, and stem cells: A revolution in surgical implants
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, London NW1 0NH, United Kingdom
Title : Biodistribution and gene targeting in regenerative medicine
Nagy Habib, Imperial College London, United Kingdom
Title : Progenitor cell mobilization and induced neutrophilia promote neovascularization and fibrinolysis in chronically ischemic tissue
Darwin Eton, Vasogenesis Inc, United States
Title : AI-integrated high-throughput tissue-chip for brain aging
Kunal Mitra, Florida Tech, United States
Title : Assembly and stability of on-chip microvasculature
Kara E McCloskey, University of California, Merced, United States